Search results
Hans Schreiber, MD PhD. Professor of Pathology. Committee on Cancer Biology. Committee on Immunology. Websites: Research Network Profile. Contact: hszz@uchicago.edu. Graduate Programs: Cancer Biology, Immunology, UChicago Biosciences.
Apr 1, 2003 · overview. The main focus of this laboratory is to study the fundamental mechanisms that govern the interaction of cancer cells with the immune system. In particular, our laboratory is trying to exploit the fact that cancer cells usually carry cancer-specific mutations and antigens, and that under certain conditions, the immune system ...
- Professor
Hans Schreiber. Experimental research on the immune response to transplanted tumors has led to pioneering discoveries that laid many of the foundations for the current field of immunology ...
Dr. Hans Schreiber, MD, DMSc, PhD, is a professor in the Department of Pathology, the Cancer Research Center, and the Committees on Cancer Biology and Immunology at the University of Chicago.
Oct 20, 2022 · Hans Schreiber, MD, PhD, was recognized for his dedication and significant contributions to the promising field of cellular immunotherapy for cancer treatment.
Jan 18, 2017 · The idea that T cells can recognize new epitopes (neoepitopes) generated by mutation or transcriptional aberrations in cancer originated in the 1980s from the work of Thierry Boon, Hans...
The main focus of this laboratory is to study the fundamental mechanisms that govern the interaction of cancer cells with the immune system. In particular, our laboratory is trying to exploit the fact that cancer cells usually carry cancer-specific mutations and antigens, and that under certain conditions, the immune system can destroy cancer cells even after they have disseminated in the body.
